Pivotal bioVenture Partners Fund I, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1695076. 1 Form 4 filing on record with FilingPulse; latest filed 2025-11-12.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2025-11-12 to 2025-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Evommune, Inc. (EVMN) | Director, 10% owner | 1 | — | — | 12 |
Form 4 filings — Pivotal bioVenture Partners Fund I, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-11-12 | 4 | Evommune, Inc. (EVMN) jointly with Pivotal bioVenture Partners Fund I G.P., L.P., Pivotal bioVenture Partners Fund I U.G.P. Ltd | Conversion (C): 1,441,032 · Conversion (C): 1,632,441 · Conversion (C): 294,502 · Conversion (C): 7,145,647 (derivative) · Conversion (C): 3,572,816 (derivative) · Conversion (C): 2,582,243 (derivative) · +6 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1695076 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →